Concerning the NKG2 family, characteristic from NK cells, we evaluated the expression of the inhibitory receptor NKG2A and the activating receptors NKG2C and NKG2D on NKT-like cells from CML patients. This evidence concerns the gene KLRC2 and chronic myelogenous leukemia, BCR-ABL1 positive.